Keywords: cell cycle; aminolaevulinic acid; photodynamic therapy; in vitro Photodynamic therapy (PDT) is an anti-cancer therapy that damages cells bv the generation of reactive oxygen species due to the interaction of light. oxygen and a photoactive chemical (Weishaupt et al. 1976) . It has been shown to be effective in the treatment of a wide vanrety of neoplasms including bladder cancer (Kriegmair et al. 1996) and carcinoma in situ of the bladder (D' Hallewin and Baert. 1995) . oesophageal cancer (Sibille et al. 1995) . a vaniety of skin cancers (Dougherty et al, 1978) and gastric cancer (Hayata et al. 1985) . However, there is often a substantial recurrence rate or incomplete response rate possibly because of focal areas of under treatment (Hayata et al. 1985) . Histological examination of treated tissues has revealed small islands of viable cells that may serve as foci for these recurrences (Suzuki et al. 1987) . This is thought to be due to inadequate light penetration to all areas of the cancer, or to resistant cells in areas of hypoxia (Moan and Sommer, 1985) . Intrinsic cellular resistance to PDT (for example due to effective free radical scavenging) or inadequate photosensitizer levels within the cell may also be important factors.
Aminolaexvulinic acid (ALA) is the prodrug of the photosensitizer protoporphyrin IX (PpIX). After ALA administration, cells generate PpIX via the haem biosynthetic enzyme system (Berlin et al, 1956 ). Sensitivity to ALA-induced PDT depends. in part. on the PpIX generation rate within the cell. The metabolic activity of a cell may vary with the phase of the cell cycle (Kaczmarek. 1986) . and the activity of cellular enzymes may fluctuate in a cell Received 18 August 1997
Revised 11 December 1997 Accepted 16 December 1997 Correspondence to: L Wyid cycle-dependent manner (Churchill and Studzinski. 1970) . Therefore, cells in certain phases of the cell cycle may produce different amounts of PpIX resulting in differential levels of PDT sensitivity. Actively proliferating cells produce more PpIX on incubation with ALA than quiescent cells (Schick et al. 1995) . This may be related to the intracellular availability of iron. with iron-depleted cells generating PpIX more rapidly (RittenhouseDiakun et al. 1995) . S-phase progression can be inhibited by iron withdrawal (Nocka and Pelus. 1988) . possibly because of the iron requirements of DNA synthetic enzymes such as ribonucleoside diphosphate reductase. which requires two iron atoms for activity (Brown et al. 1969) . Thus. it might be expected that the iron requirements of S-phase cells would deplete intracellular stores. allowing increased production of PpIX. It is known that transferrin receptor expression on the cell surface is maximal in the G,. S-and M-phases of the cell cycle (indicating relative iron depletion) and falls by a factor of 4 during G1 (Necker and Cossman. 1983). Fukuda et al (1993) studied the relationship between the phase of the cell cycle and the rates of PpIX generation using an epithelial cell line and serum withdrawal as a means of inducing cell synchronization. This study did not demonstrate any significant differences between cell cycle phases. although a trend towards higher PpIX production by G, cells was noted.
The variability in PDT sensitivity with the cell cycle may be analogous to that seen using radiotherapy. Radiotherapy. like PDT. induces cytotoxicity through the generation of reactive oxygen species (Hewitt and Wilson. 1959) . Both radiotherapy and PDT are known to cause DNA damage (Gomer. 1980) . although PDT causes fewer DNA strand breaks per effective dose unit than radiotherapy (Moan et al. 1983) . Cells are most sensitive to radiotherapy during mitosis. late G1 and early S-phase. and are relatively resistant in late S-phase and early G (Terasima and Cell cycle influences photodynamic therapy 51 Tolmach, 1963) . Cells in G, are also relatively radiosensitive (Humphrey and Dewey. 1965 (DMEM, Gibco) supplemented with 10% newbom calf serum (Gibco) and 1% penicillin and streptomycin solution (10 000 IU ml-' and 10 000 jig ml-', respectively, Gibco).
Cell cycle duration: bromodeoxyuridine (BrdU) pulse labelling A modified BrdU pulse-labelling technique was used to determine cell cycle duration (Dolbeare and Seldon, 1994) . BrdU is a thymidine analogue, taken up exclusively by cells in S-phase, which can then be detected by specific fluorescent-labelled monoclonal antibodies. Exponentially growing cells (2 x 106) were incubated with 10 gm bromodeoxyuridine (Sigma Chemicals, UK) in complete media for 30 min. The cells were then washed twice in phosphatebuffered saline (PBS, Sigma Chemicals, UK) and incubated in complete media without BrdU. At 3-h intervals for 15 h cells were removed from flasks by trypsinization (trypsin 0.05% and EDTA 0.02%. Gibco) and fixed in 1% paraformaldehyde (Sigma Chemicals, UK) for 5 min at room temperature. The cells were then permeabilized in 70% methanol at 4°C for 24 h. DNA was denatured with 2 M hydrochloric acid with 1 mg ml-pepsin A (derived from porcine stomach mucosa, Sigma Chemicals, UK) for 1 h at room temperature. The acid was neutralized with 0.1 M borax solution (Sigma Chemicals, UK). Cells were incubated with anti-BrdU antibody (25 jg ml-l monoclonal mouse anti-BrdU.
Dako, UK) for 30 min at 370C followed by a second incubation with a fluorescein isothiocyanate (FITC) conjugated second antibody (7 jg ml-' goat anti-mouse, Caltag Laboratories, CA, USA) for a further 30 min at 37°C. Cells were washed with PBS with 1% fetal calf serum (Gibco) between antibody additions to reduce nonspecific antibody binding. Cellular DNA was then labelled with propidium iodide (PI, 50 jg ml-l, Sigma Chemicals, UK) to which RNAase (Sigma Chemicals. UK) was added to denature any double-stranded RNA before being run on the cytometer (Beckton Dickinson FACSort). Cells were analysed with excitation at 488 nm and emission at 630 (± 22) nm for propidium iodide and 530 (± 30) nm for FITC. Three repeats were performed.
Cell synchronization
This was based on the method of Stein et al (1995) . Exponentially growing cells were treated with complete media containing 2 mm thymidine (Sigma Chemicals, UK), which inhibits cell cycle progression for cells in S-phase and blocks entry of further cells into S-phase. The treatment time corresponded to the total duration of G. M-phase and G1, as determined by BrdU pulse labelling, to allow cells in G,. M-phase and GI to accumulate at the GI/S boundary. The thymidine block was then removed, the cells washed and replaced in media containing 24 gM deoxycytidine.
which replenishes the nucleotide precursor pools. and incubated for a time corresponding to the duration of S-phase. Cells previously blocked in S-phase and those held at the G,/S boundary then pass through S-phase and into G,. The thymidine block is then reapplied for the G, + M + G time interval. to allow all cells to progress to the G,/S boundary but prevent entry into S-phase. On release of this second block with deoxycytidine. all of the cells should progress through the cell cycle in a synchronized manner. To confirm that synchronization had occurred. synchronized cells were labelled with BrdU. sampled at 3-h intervals and processed using flow cytometry. This allowed quantification of the proportion of cells in each phase of the cell cycle at different times after release of the block. The effect of inclusion of I mM ALA (Sigma) in the culture media of synchronized cells during cell cycle progression was also studied.
The resultant synchronized DNA histograms were analysed using a curve-fitting program (ModFit LT. Verity Software House). which determined the percentage of cells in each phase of the cell cycle at each time point. (Five repeats of each experiment were performed.)
PpIX deWmination
This method has been described in a previous publication (Wyld et al, 1997) . In brief, flasks of synchronized cells were obtained as above. At times corresponding to S-phase. G,/M and G,. cells were incubated with 1 mm ALA in complete medium for 1 or 4 h. in the dark, at 37°C. PpIX concentrations in the cells and the media were then determined by spectrofluorimetry (excitation at 406 nm. emission at 60(4 nm, Perkin-Elmer LS-3 fluorescence spectrometer). Values were expressed as either ng PpIX per I05 cell or ng PpIX per jg cellular protein. The cell count was determined using haemocytometry (Freshney. 1987 ) and the protein content by the micro-Lowry method (Lowry et al. 1951) . Six triplicate repeats were performed.
MTT assay
This technique allows quantification of cell survival after a cytotoxic insult. MTT (3-(4,5-dimethylthiazol-2yl)-2.5-diphenyl tetrazolium bromide, Sigma Chemicals, UK) is metabolized by the mitochondrial enzyme. lactate dehydrogenase to a violet-coloured formazan product in direct proportion to the number of cells present over a predetermined range (Stratford and Stephens. 1989) . The optical density of the product is quantified spectrophotometrically on a 96-well-plate reader. MTT, 0.5 mg ml-l. was added to each well of a 96-well plate and incubated for 2 h. The medium was then removed and replaced with 200 jl of dimethyl sulphoxide (DMSO) (Sigma. UK) to solubilize the fonnazan. The plate was then read on an ELISA plate reader (Anthos Labtec Instruments) at 550 nm absorbance. The initial plating density was determined by plating serial cell dilutions into the wells of a 96-well plate and comparing the direct haemocytometer count with the colour density produced. All further experiments used a cell density within the linear portion of the curve. Cell cycle progression U.. ' .ing BrdU pule labelling the duration o1 the ditterent pha--e' the cell cxcle xxere calculated to be S-pha'.e 6 h: G 3 h and G 6 h xxith an oxerall cell cxcle duration o1 15 h. Thi' i' in agreement xxith the population doubling time 1 I -_29 h) prexiouklx determined in thi' laboratorx Cell synchronization Figure 1 . From these data. the optimal sampling times for each phase of the cell cycle after release of the thymidine block were determined. Figure 4 and mean cell cycle-specific PpIX fluorescence values are shown in Figure 5 . 
